Validated EMPEROR-Preserved Risk Models Stratify Prognosis in FINEARTS-HF, While Finerenone Benefits Remain Consistent Across Baseline Risk

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.